Catalyst Capital Advisors LLC Repligen Corp Transaction History

Catalyst Capital Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$160.42 - $256.21 $616,012 - $983,846	-3,840 Reduced 85.14%	670 $125,000
Q2 2022 Aug 09, 2022	BUY	$140.68 - $188.02 $567,081 - $757,908	4,031 Added 841.54%	4,510 $732,000
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $9,510 - $15,219	-59 Reduced 10.97%	479 $90,000
Q4 2021 Feb 10, 2022	BUY	$247.59 - $304.47 $742 - $913	3 Added 0.56%	538 $143,000
Q3 2021 Nov 09, 2021	BUY	$194.77 - $324.21 $10,907 - $18,155	56 Added 11.69%	535 $154,000
Q2 2021 Aug 06, 2021	SELL	$165.87 - $220.95 $108,644 - $144,722	-655 Reduced 57.76%	479 $96,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $71,246 - $89,372	395 Added 53.45%	1,134 $220,000
Q4 2020 Feb 05, 2021	BUY	$148.08 - $206.57 $91,069 - $127,040	615 Added 495.97%	739 $142,000
Q2 2020 Aug 10, 2020	SELL	$94.33 - $140.48 $46,787 - $69,678	-496 Reduced 80.0%	124 $15,000
Q1 2020 May 12, 2020	SELL	$84.96 - $109.14 $304,156 - $390,721	-3,580 Reduced 85.24%	620 $60,000
Q4 2019 Feb 06, 2020	SELL	$73.84 - $93.08 $169,832 - $214,084	-2,300 Reduced 35.38%	4,200 $389,000
Q3 2019 Nov 05, 2019	SELL	$76.65 - $95.51 $321,930 - $401,142	-4,200 Reduced 39.25%	6,500 $498,000
Q1 2019 May 08, 2019	SELL	$49.45 - $62.8 $187,910 - $238,640	-3,800 Reduced 26.21%	10,700 $632,000
Q4 2018 Feb 07, 2019	SELL	$48.26 - $68.88 $308,864 - $440,832	-6,400 Reduced 30.62%	14,500 $765,000
Q2 2018 Aug 07, 2018	BUY	$35.26 - $47.04 $736,934 - $983,136	20,900 New	20,900 $983,000

494

57.6M

75.6K

521K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.8B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.